A Duke Health-led research team has identified a key marker that will help speed effective vaccine designs for cytomegalovirus (CMV), the most common congenital infection worldwide and a leading cause of infant brain damage.
Tuesday 26 January 2021
medicalxpress - 3 month ago
Researchers identify key marker to help speed development of CMV vaccines
Latest News
